Eli Lilly & Co. (LLY)
1051.48
+41.96
(+4.16%)
USD |
NYSE |
Feb 23, 11:03
Eli Lilly Market Cap : 991.92B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 203.45B |
| Biogen, Inc. | 28.66B |
| Regeneron Pharmaceuticals, Inc. | 82.94B |
| Viking Therapeutics, Inc. | 3.906B |
| Moderna, Inc. | 20.15B |
Market Cap Related Metrics
| PE Ratio | 46.55 |
| PS Ratio | 14.70 |
| PEG Ratio | 0.4818 |
| Price to Book Value | 37.38 |
| Price to Free Cash Flow | 160.61 |
| Price | 1051.48 |
| Earnings Yield | 2.15% |
| PEGY Ratio | 0.4787 |
| Operating PE Ratio | 32.26 |
| Normalized PE Ratio | 42.38 |